Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $693.43M.
ENTERPRISE VALUE (EV)
$693.43M
Sana Biotechnology, Inc.
Market Cap
$765.30M
Enterprise Value (EV)
$693.43M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Sana Biotechnology, Inc. (SANA) | $765.30M | $693.43M |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | $832.04M |
| Geron Corporation (GERN)vs › | $776.24M | $835.74M |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | $795.70M |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | $724.52M |
| Varex Imaging Corporation (VREX)vs › | $778.01M | $1.05B |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | $736.73M |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | $2.81B |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | $749.47M |
Market Cap
$765.30M
Total Debt
$0.00
Cash
$71.87M
Enterprise Value
$693.43M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
